Correction: The nuclear-cytoplasmic trafficking of a chromatin-modifying and remodelling protein (KMT2C), in osteosarcoma

Caterina Chiappetta; Chiara Puggioni; Raffaella Carletti; Vincenzo Petrozza; Carlo Della Rocca; Claudio Di Cristofano

doi:10.18632/oncotarget.26240

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: The nuclear-cytoplasmic trafficking of a chromatin-modifying and remodelling protein (KMT2C), in osteosarcoma

PDF | How to cite

Oncotarget. 2018; 9:35195-35195. https://doi.org/10.18632/oncotarget.26240

Metrics: PDF 1239 views | ?

Caterina Chiappetta¹, Chiara Puggioni¹, Raffaella Carletti¹, Vincenzo Petrozza¹, Carlo Della Rocca¹ and Claudio Di Cristofano¹

¹ UOC of Pathology, Department of Medical-Surgical Sciences and Bio-Technologies, Sapienza University of Rome, Latina, Italy

Published: October 12, 2018

This article has been corrected: The correct author name is given below:

Claudio Di Cristofano

Original article: Oncotarget. 2018; 9:30624-30634. DOI: https://doi.org/10.18632/oncotarget.25755.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26240

Publication Alerts

Corrections:

Correction: The nuclear-cytoplasmic trafficking of a chromatin-modifying and remodelling protein (KMT2C), in osteosarcoma